Medically reviewed by Cordelia Nwankwo, MD Key Takeaways CMV is common and stays in the body for life.Congenital CMV can lead ...

Human cytomegalovirus infections are still associated with severe morbidity and mortality in immunocompromised individuals, despite the availability of five drugs that are currently licensed for ...

Explore the benefits of prenatal DNA screening to detect cytomegalovirus in early pregnancy for better health decisions.

A new study indicates that noninvasive prenatal screening (NIPS) performed using a low-cost form of whole genome sequencing ...

From February 2023, when the program began, to February 2024, 184 cases of congenital CMV infection or disease were identified among 60,115 infants screened using dried blood spot polymerase chain ...

Viruses hijack the molecular machinery in human cells to survive and replicate, often damaging those host cells in the process. Researchers at the University of California San Diego School of Medicine ...

NEW ORLEANS — Maribavir, an antiviral once deemed promising for cytomegalovirus (CMV) infection but discarded after a negative phase 3 trial, has been shown to be effective in treatment-resistant and ...

Cytomegalovirus (CMV) infection continues to pose a significant challenge in the context of haematopoietic stem cell transplantation (HSCT). The virus, which often remains dormant before reactivation ...

Bone marrow transplantation is a life-saving therapy for patients with blood cancers like leukemia or lymphoma. However, the depletion of the patient's immune system prior to transplantation can put ...

Evaxion’s AI-Immunology™ platform has discovered novel CMV antigens that significantly reduce viral infection in preclinical models EVX-V1 is a next-generation, multi-component vaccine program ...

CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company’s ...